This inventor holds 1 USPTO granted patent. Top assignees: Keio University, Shionogi Company Limited. Active years: 2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 361 
1 out of 1,001 
Years Active: 2018
Title: Motoaki Komatsu: Innovator in Chronic Kidney Disease Treatment
Introduction
Motoaki Komatsu is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of chronic kidney disease. His innovative approach focuses on targeting specific enzymes to improve therapeutic outcomes for patients.
Latest Patents
Motoaki Komatsu holds a patent for a pharmaceutical composition aimed at treating chronic kidney disease. This invention involves a therapeutic agent that comprises a substance which inhibits the enzymatic activity of NNMT or suppresses NNMT gene expression. Additionally, it includes a method for screening a therapeutic agent that targets the NNMT enzyme or NNMT gene.
Career Highlights
Throughout his career, Komatsu has worked with reputable organizations such as Shionogi & Company Limited and Keio University. His experience in these institutions has allowed him to develop and refine his innovative ideas in the pharmaceutical sector.
Collaborations
He has collaborated with notable colleagues, including Takashi Ono and Katsutoshi Yamada. These partnerships have contributed to the advancement of his research and the successful development of his patent.
Conclusion
Motoaki Komatsu's work in the field of chronic kidney disease treatment exemplifies the impact of innovation in healthcare. His patent reflects a significant step forward in therapeutic options for patients suffering from this condition.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile